DOSAGE FORMS FOR ORAL ADMINISTRATION OF ACTIVE SUBSTANCES
In one aspect, the present invention relates to a system for the modified release of one or more active ingredients, comprising a polymeric matrix based on hyaluronic acid with molecular weight ranging from 100 to 100,000 Daltons and a non-ionic polymer which jellifies in contact with water, in whic...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; hun |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In one aspect, the present invention relates to a system for the modified release of one or more active ingredients, comprising a polymeric matrix based on hyaluronic acid with molecular weight ranging from 100 to 100,000 Daltons and a non-ionic polymer which jellifies in contact with water, in which one or more active ingredients are dispersed, optionally in form of microgranules or microcapsules. |
---|